Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ADV7103 in Distal Renal Tubular Acidosis (dRTA)
NCT03644706Phase 3Terminated
- Sponsor
- Advicenne
- Start
- Sep 2021
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 3, randomised, double-blind trial in distal renal tubular acidosis (dRTA) comparing ADV7103 with Placebo Comparator (2 arms). Primary endpoint: Change in Blood Bicarbonate Levels at day 6. Started Sep 2021; status: terminated.
02
Drugs
Sibnayal
03
Conditions
distal renal tubular acidosis (dRTA)
Beyond the preview
Go deeper on NCT03644706.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03644706.